Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 7/20 | 0.56 |
| ▸ | PRKD3 | O94806 | 7/20 | 0.56 |
| ▸ | PRKCG | P05129 | 7/20 | 0.56 |
| ▸ | PRKCB | P05771 | 7/20 | 0.56 |
| ▸ | PRKCA | P17252 | 7/20 | 0.56 |
| ▸ | PRKCH | P24723 | 7/20 | 0.56 |
| ▸ | PRKCI | P41743 | 7/20 | 0.56 |
| ▸ | PRKCE | Q02156 | 7/20 | 0.56 |
| ▸ | PRKCQ | Q04759 | 7/20 | 0.56 |
| ▸ | PRKCZ | Q05513 | 7/20 | 0.56 |
| ▸ | PRKCD | Q05655 | 7/20 | 0.56 |
| ▸ | PRKD1 | Q15139 | 7/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 6/20 | 0.56 |
| ▸ | PRKACA | P17612 | 5/20 | 0.56 |
| ▸ | PRKACG | P22612 | 5/20 | 0.56 |
| ▸ | PRKACB | P22694 | 5/20 | 0.56 |
| ▸ | MEN1 | O00255 | 4/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.56 |
| ▸ | NFKB1 | P19838 | 4/20 | 0.56 |
| ▸ | TP53 | P04637 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29696494 | 1.00 | CYP3A4 (0.56) | CYP3A4PRKD3PRKCGPRKCBPRKCA | |
| Hydrochloric Acid SCHEMBL9477757 | 0.98 | LMNA (0.57) | CYP3A4PRKD3PRKCGPRKCBPRKCA | |
| Hydrochloric Acid SCHEMBL8670953 | 0.98 | LMNA (0.57) | CYP3A4PRKD3PRKCGPRKCBPRKCA | |
| Sulfuric Acid SCHEMBL29120407 | 0.98 | CYP3A4 (0.55) | CYP3A4PRKD3PRKCGPRKCBPRKCA | |
| Fluoride SCHEMBL28263329 | 0.98 | CYP3A4 (0.55) | CYP3A4PRKD3PRKCGPRKCBPRKCA | |
| SCHEMBL26422606 | 0.86 | TNF (0.46) | CYP3A4PRKD3PRKCGPRKCBPRKCA | |
| SCHEMBL6967362 | 0.85 | CYP3A4 (0.59) | CYP3A4PRKD3PRKCGPRKCBPRKCA | |
| Hydrochloric Acid SCHEMBL27788261 | 0.84 | TNF (0.45) | CYP3A4PRKD3PRKCGPRKCBPRKCA | |
| SCHEMBL115053 | 0.82 | CYP3A4 (0.56) | CYP3A4PRKD3PRKCGPRKCBPRKCA | |
| SCHEMBL30075444 | 0.82 | CA1 (0.61) | CYP3A4PRKD3PRKCGPRKCBPRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 806 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122039032-A | Integrated manufacturing method of high-precision multi-chamber millimeter wave waveguide filter antenna | 大连大学 | 2026-05-15 | — | — | CN | claimed |
| CN-119954776-A | Preparation method and application of fasudil dichloroacetate | 中国药科大学 | 2025-05-09 | — | — | CN | claimed |
| CN-119775577-A | Proton conductive cobalt-based single-molecule magnet difunctional material and preparation method and application thereof | 黄冈师范学院 | 2025-04-08 | — | — | CN | claimed |
| CN-119661397-A | Leisha amphetamine salt single crystal, chiral isomer salt single crystal, preparation method and application thereof | 四川科瑞德制药股份有限公司 | 2025-03-21 | — | — | CN | claimed |
| WO-2024112610-A2 | PREPARATION METHOD OF FASUDIL HYDROCHLORIDE HEMIHYDRATE | WOOLSEY PHARMACEUTICALS, INC. (US) | 2024-05-30 | — | — | WO | claimed |
| CN-117907492-B | High performance liquid chromatography method for simultaneously qualitatively and quantitatively detecting 5-isoquinoline sulfonic acid and six impurities thereof | 山东新华制药股份有限公司 | 2024-05-24 | — | — | CN | claimed |
| CN-117907492-A | High performance liquid chromatography method for simultaneously qualitatively and quantitatively detecting 5-isoquinoline sulfonic acid and six impurities thereof | 山东新华制药股份有限公司 | 2024-04-19 | — | — | CN | claimed |
| CN-117229213-A | Efficient synthetic method of carbamazepine | 浙江九洲药业股份有限公司 | 2023-12-15 | — | — | CN | claimed |
| CN-117126107-A | Synthesis method of substituted iminostilbene compound | 浙江九洲药业股份有限公司 | 2023-11-28 | — | — | CN | claimed |
| CN-114577920-B | Method for detecting fasudil hydrochloride and related substances thereof | 远大医药（中国）有限公司 | 2023-08-22 | — | — | CN | claimed |
| EP-1395261-A2 | PYRIDYLPYRIMIDINE DERIVATIVES AS EFFECTIVE COMPOUNDS AGAINST PRION DISEASES | Axxima Pharmaceuticals Aktiengesellschaft (DE) | 2004-03-10 | — | — | EP | claimed |
| US-20030176443-A1 | Pyridylpyrimidine derivatives as effective compounds against prion diseases | GPC BIOTECH FORSCHUNGSGESELLSCHAFT MBH (DE) | 2003-09-18 | — | — | US | claimed |
| WO-2003055478-A1 | GLYT1 TRANSPORTER INHIBITORS AND USES THEREOF IN TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS | SMITHKLINE BEECHAM P.L.C. (GB) | 2003-07-10 | — | — | WO | claimed |
| WO-2002093164-A2 | PYRIDYLPYRIMIDINE DERIVATIVES AS EFFECTIVE COMPOUNDS AGAINST PRION DISEASES | AXXIMA PHARMACEUTICALS AG (DE) | 2002-11-21 | — | — | WO | claimed |
| US-6376252-B1 | PIECES OF BIBULOUS PAPER MATRIX OF A SIZE SUCH THAT THE PIECES CAN BE INCONSPICUOUSLY MIXED WITH THE CAT BOX FILLER IMPREGNATED WITH AN AQUEOUS-BASED GROUP OF STABILIZER COMPONENTS COMPRISING 5-ISOQUINOLINE SULFONIC ACID | ENVIRONMENTAL TEST SYSTEMS, INC. | 2002-04-23 | — | — | US | claimed |
| EP-0853618-A4 | SUBSTITUTED (SULFINIC ACID, SULFONIC ACID, SULFONYLAMINO OR SULFINYLAMINO) N- (AMINOIMINOMETHYL)PHENYLALKYL]-AZAHETEROCYCLYLAMIDE COMPOUNDS | RHONE POULENC RORER PHARMA (US) | 2000-03-15 | — | — | EP | claimed |
| US-5958918-A | Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N- (aminominomethyl)phenylalkyl!-azaheterocyclylamide compounds | RHONE-POULENC RORER PHARMACEUTICALS INC. | 1999-09-28 | — | — | US | claimed |
| CN-1190395-A | Substituted (sulfonic, sulfinic, sulfonamido or sulfonamido) N- [ aminoiminomethyl) phenylalkyl ] -azaheterocyclic amide compounds | RHONE POULENC RORER PHARMA (US) | 1998-08-12 | — | — | CN | claimed |
| EP-0853618-A1 | SUBSTITUTED (SULFINIC ACID, SULFONIC ACID, SULFONYLAMINO OR SULFINYLAMINO) N- (AMINOIMINOMETHYL)PHENYLALKYL]-AZAHETEROCYCLYLAMIDE COMPOUNDS | RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) | 1998-07-22 | — | — | EP | claimed |
| WO-1996040679-A1 | SUBSTITUTED (SULFINIC ACID, SULFONIC ACID, SULFONYLAMINO OR SULFINYLAMINO) N-[(AMINOIMINOMETHYL)PHENYLALKYL]-AZAHETEROCYCLYLAMIDE COMPOUNDS | RHÔNE-POULENC RORER PHARMACEUTICALS INC. (US) | 1996-12-19 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030176443-A1 | Pyridylpyrimidine derivatives as effective compounds against prion diseases | PRNP, PPM1D, PPM1F | CYP3A4 3251/4885PRKD3 44/4885PRKCG 270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.